BIODESIX, INC. Interest Expense Nonoperating
BIODESIX, INC. (BDSX) reported Interest Expense Nonoperating of $1.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- BIODESIX, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $1.98M, a 4.43% increase year-over-year.
- BIODESIX, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $1.98M, a 17.33% increase year-over-year.
- BIODESIX, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $2.06M, a 17.52% increase year-over-year.
- BIODESIX, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $2.07M, a 1.62% increase year-over-year.
- BIODESIX, INC. interest expense nonoperating for fiscal 2025 was $7.72M, a 6.56% decline from fiscal 2024.
- BIODESIX, INC. interest expense nonoperating for fiscal 2024 was $8.26M, a 13.40% decline from fiscal 2023.
- BIODESIX, INC. interest expense nonoperating for fiscal 2023 was $9.54M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-05 | $3.96M 10-Q · filed 2026-08-05 | $6.02M derived: sum of 3 quarters · filed 2026-08-05 | $8.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.98M 10-Q · filed 2026-05-04 | $4.04M derived: sum of 2 quarters · filed 2026-05-04 | $6.11M derived: sum of 3 quarters · filed 2026-05-04 | $8.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.13M derived: sum of 2 quarters · filed 2026-02-26 | $6.03M derived: sum of 3 quarters · filed 2026-08-05 | $7.72M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.07M 10-Q · filed 2025-11-03 | $3.97M derived: sum of 2 quarters · filed 2026-08-05 | $5.66M 10-Q · filed 2025-11-03 | $7.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.90M 10-Q · filed 2026-08-05 | $3.58M 10-Q · filed 2026-08-05 | $5.33M derived: sum of 3 quarters · filed 2026-08-05 | $7.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.69M 10-Q · filed 2026-05-04 | $3.44M derived: sum of 2 quarters · filed 2026-05-04 | $5.48M derived: sum of 3 quarters · filed 2026-05-04 | $7.41M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.79M derived: sum of 2 quarters · filed 2026-02-26 | $5.73M derived: sum of 3 quarters · filed 2026-02-26 | $8.26M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-03 | $3.98M derived: sum of 2 quarters · filed 2025-11-03 | $6.51M 10-Q · filed 2025-11-03 | $8.84M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $1.94M 10-Q · filed 2025-08-07 | $4.46M 10-Q · filed 2025-08-07 | $6.79M derived: sum of 3 quarters · filed 2025-08-07 | $9.18M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.53M 10-Q · filed 2025-05-13 | $4.86M derived: sum of 2 quarters · filed 2025-05-13 | $7.24M derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.71M derived: sum of 2 quarters · filed 2025-03-03 | $9.54M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $2.39M 10-Q · filed 2024-11-01 | $7.21M 10-Q · filed 2024-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |